Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 37, pseudogene (RN7SL37P) is classified as a processed pseudogene—a genomic DNA segment that resembles the functional 7SL RNA, a key component of the signal recognition particle (SRP), but cannot produce a functional RNA or protein product. Pseudogenes arise through gene duplication or retrotransposition and accumulate mutations that inactivate them. While the functional 7SL RNA plays a central role in protein targeting and translocation within cells, pseudogenes like RN7SL37P have lost these physiological activities. There is no evidence suggesting RN7SL37P has any role in disease, drug interaction, or clinical biomarker utility. It is not considered a therapeutic target, and its presence may complicate molecular studies due to sequence similarity to functional genes, potentially causing PCR or sequencing bias.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 37, pseudogene (RN7SL37P).